| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.29▼ | 4.38▼ | 4.39▼ | 4.40▼ | 1.84▲ |
| MA10 | 4.38▼ | 4.61▼ | 4.52▼ | 3.27▲ | 1.01▲ |
| MA20 | 4.51▼ | 4.55▼ | 4.48▼ | 1.72▲ | 0.77▲ |
| MA50 | 4.55▼ | 4.59▼ | 3.28▲ | 0.80▲ | 0.63▲ |
| MA100 | 4.44▼ | 2.48▲ | 1.72▲ | 0.72▲ | 0.92▲ |
| MA200 | 3.50▲ | 1.32▲ | 0.95▲ | 0.64▲ | 2.46▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.043▼ | -0.082▼ | -0.136▼ | 0.369▲ | 0.407▲ |
| RSI | 26.371▼ | 42.296▼ | 50.234▲ | 76.077▲ | 86.520▲ |
| STOCH | 1.190▼ | 7.784▼ | 11.249▼ | 67.552 | 29.525 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -35.156 | -35.156 |
| CCI | -148.425▼ | -121.818▼ | -140.782▼ | 55.044 | 221.271▲ |
|
Wednesday, April 01, 2026 04:49 PM
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, ...
|
|
Tuesday, March 31, 2026 02:05 PM
Initiated a formal process to monetize assets Implemented a restructuring plan to significantly reduce operating expenses and extend runway SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- BioAtla, Inc.
|
|
Tuesday, March 31, 2026 01:16 PM
(NASDAQ: BCAB or the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/04/26 | 4.43 | 4.45 | 4.20 | 4.27 | 21,243 |
| 13/04/26 | 4.50 | 5.22 | 4.31 | 4.31 | 49,355 |
| 10/04/26 | 4.44 | 4.5899 | 4.33 | 4.46 | 18,739 |
| 09/04/26 | 4.39 | 4.6826 | 4.35 | 4.52 | 37,290 |
| 08/04/26 | 4.80 | 4.90 | 4.202 | 4.44 | 70,761 |
| 07/04/26 | 5.37 | 5.37 | 3.92 | 4.66 | 256,798 |
| 06/04/26 | 6.52 | 6.52 | 5.42 | 5.65 | 132,709 |
| 02/04/26 | 0.137 | 0.1388 | 0.1275 | 0.1304 | 1,067,222 |
| 01/04/26 | 0.1242 | 0.138 | 0.12 | 0.1346 | 2,998,967 |
| 31/03/26 | 0.16 | 0.164 | 0.145 | 0.161 | 1,412,473 |
|
|
||||
|
|
||||
|
|